Screening and Management of Primary Aldosteronism: Closing the Gap in Hypertension Care
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Drs Marwah Abdalla and Vivek Bhalla discuss the screening, management, and future of primary aldosteronism — a common cause of secondary hypertension.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1003186. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Secondary Hypertension https://www.ncbi.nlm.nih.gov/books/NBK544305/
Primary Aldosteronism https://emedicine.medscape.com/article/127080-overview
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-Sectional Study https://pubmed.ncbi.nlm.nih.gov/32449886/
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://pubmed.ncbi.nlm.nih.gov/40811516/
Expanding the Search for Primary Aldosteronism in Clinical Settings https://pubmed.ncbi.nlm.nih.gov/40811492/
Primary Hyperaldosteronism in Hypertension https://www.escardio.org/Councils/Council-for-Cardiology-Practice-(CCP)/Cardiopractice/primary-hyperaldosteronism-in-hypertension
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline https://pubmed.ncbi.nlm.nih.gov/40658480/
Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys https://pubmed.ncbi.nlm.nih.gov/36375469/
The Effect of Spironolactone on Morbidity and Mortality in Patients With Severe Heart Failure. Randomized Aldactone Evaluation Study Investigators https://pubmed.ncbi.nlm.nih.gov/10471456/
Cardiometabolic Outcomes and Mortality in Medically Treated Primary Aldosteronism: A Retrospective Cohort Study https://pubmed.ncbi.nlm.nih.gov/29129576/
Aldosterone Synthase Inhibitors for Cardiorenal Protection: Ready for Prime Time? https://pubmed.ncbi.nlm.nih.gov/39557029/